Allergic Rhinitis News and Research

RSS
Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Mylan receives final FDA approval for Montelukast Sodium Tablets ANDA

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

Qualitest confirms launch of generic Singulair Tablets for asthma and allergic rhinitis

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

First generic versions of Singulair receive FDA approval for treatment of asthma, allergies

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Food allergies more prevalent among urban children

Food allergies more prevalent among urban children

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

$6.4 million awarded to investigate mechanisms of allergy tolerance generated by Circassia’s ToleroMune Treatment

Childhood obesity risk may be increased by caesarean section delivery

Childhood obesity risk may be increased by caesarean section delivery

Mood disorders not linked to nasal obstruction

Mood disorders not linked to nasal obstruction

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

ACAAI to conduct 16th annual Nationwide Asthma Screening Program

Meda opens China affiliate based in Beijing

Meda opens China affiliate based in Beijing

FDA approves Teva's QNASL nasal aerosol corticosteroid

FDA approves Teva's QNASL nasal aerosol corticosteroid

Enrollment complete in HAL Allergy PURETHAL Mites Phase II trial for allergic rhinitis/rhinoconjunctivitis

Enrollment complete in HAL Allergy PURETHAL Mites Phase II trial for allergic rhinitis/rhinoconjunctivitis

Meda's Astepro receives registration approval in Europe

Meda's Astepro receives registration approval in Europe

AAFA releases new 'Spring Allergy Capital' rankings

AAFA releases new 'Spring Allergy Capital' rankings

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Meda announces positive results from three MP29-02 studies on allergic rhinitis

Perrigo receives final approval from FDA for Desloratadine ANDA

Perrigo receives final approval from FDA for Desloratadine ANDA

Eating fish before age of nine months reduces risk of pre-school wheeze in children

Eating fish before age of nine months reduces risk of pre-school wheeze in children

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Sunovion reports positive results from ciclesonide nasal aerosol Phase III study for perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

Teva reports data from QNASL studies on seasonal and perennial allergic rhinitis

HAL Allergy initiates PURETHAL Mites PHASE II study

HAL Allergy initiates PURETHAL Mites PHASE II study